Welcome to our dedicated page for Airsculpt Technologies news (Ticker: AIRS), a resource for investors and traders seeking the latest updates and insights on Airsculpt Technologies stock.
AirSculpt Technologies Inc. (AIRS) delivers innovative body contouring solutions through its patented AirSculpt® technology, combining medical precision with minimally invasive techniques. This news hub provides investors and industry observers with essential updates on corporate developments, clinical advancements, and market positioning.
Access official press releases covering earnings reports, facility expansions, technology patents, and partnership announcements. Our curated collection enables efficient tracking of operational milestones in the competitive medical aesthetics sector.
Key coverage areas include regulatory filings, procedure innovation updates, executive leadership changes, and strategic growth initiatives. All content is sourced directly from company communications to ensure accuracy and timeliness.
Bookmark this page for streamlined monitoring of AIRS's progress in advancing body contouring technologies and expanding its North American clinic network. Verify publication dates for the latest developments in this dynamic healthcare segment.
AirSculpt Technologies, Inc. (NASDAQ:AIRS), a national provider of premium body contouring procedures, has announced significant leadership changes. Todd Magazine has stepped down as Chief Executive Officer and Board member, transitioning to an advisory role until December 31, 2024. Dennis Dean, the company's Chief Financial Officer, has been appointed as interim CEO while a search for a permanent successor is conducted.
Dr. Aaron Rollins, Executive Chairman, expressed confidence in the company's business model and growth potential. The focus will be on core body contouring procedures, reducing long-term marketing spend, and increasing fiscal discipline in response to the current economic environment. Dennis Dean emphasized the company's plan to focus on core operations, reduce expenses, and position for efficient scaling to deliver consistent revenue growth with industry-leading EBITDA margins as conditions improve.
AirSculpt Technologies, Inc. (NASDAQ: AIRS), a national provider of premium body contouring procedures, has announced its plans to report second quarter 2024 financial results. The company will release its earnings before the market opens on Friday, August 9, 2024, followed by a conference call at 8:30 a.m. Eastern Time on the same day.
Investors and interested parties can access the conference call by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13747871. Alternatively, they can request a return call for instant telephone access. A live webcast of the call will be available on the investor relations section of the AirSculpt Technologies website, with a replay accessible for approximately 90 days after the event.
AirSculpt Technologies, Inc. (NASDAQ:AIRS) reported a 2.9% increase in first-quarter cases to 3,746 and a 3.9% revenue increase to $47.6 million. Net income rose to $6.0 million from a loss in the previous year. The company plans six new center openings in 2024 and maintains revenue guidance of $220 million.
AirSculpt Technologies, Inc. announced its plans to release the first quarter 2024 financial results on May 10, 2024, followed by a conference call. The company specializes in premium body contouring procedures and invites investors to join the call for more information.
AirSculpt® Technologies, Inc., announced the relocation of its Atlanta office and the addition of the AirSculpt®+ skin tightening procedure to its offerings. The new office is in the prime Lenox Overlook area, and AirSculpt+ combines fat removal with skin tightening for enhanced results. The company has performed over 60,000 AirSculpt® cases since 2012 across premium locations in the U.S., Canada, and the U.K.
FAQ
What is the current stock price of Airsculpt Technologies (AIRS)?
What is the market cap of Airsculpt Technologies (AIRS)?
